pharmaceuticals-and-healthcare

EMEA (Europe, Middle East and Africa) Pertussis Vaccine Market Report 2017


Published On : Mar 2017

Category : Pharmaceutical

No. of Pages : 106 pages

  • $4000
  • $8000

Please click below to avail discount on this report

In this report, the EMEA Pertussis Vaccine market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Units), revenue (Million USD), market share and growth rate of Pertussis Vaccine for these regions, from 2012 to 2022 (forecast)
Europe: Germany, France, UK, Russia, Italy and Benelux;
Middle East: Saudi Arabia, Israel, UAE and Iran;
Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Pertussis Vaccine market competition by top manufacturers/players, with Pertussis Vaccine sales volume (K Units), price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including
Sanofi Pasteur
GSK
Mitsubishi Tanabe Pharma Corporation
Astellas Pharma
Minhai Biotechnology
Wuhan Institute of Biological Products
Changchun Changsheng Life Sciences
Beijing Tiantan Biological Products
Chengdu Institute of Biological Products

On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into
Whole-cell Vaccines
Acellular Vaccines

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Units), market share and growth rate of Pertussis Vaccine for each application, including
Children Application
Adults Application

In the recent times, the global market for Emea europe middle east and africa pertussis vaccine market report 2017 has surfaced as one of the most promising markets in the pharmaceutical industry, thanks to the significant rise in research and development activities by leading vendors of Emea europe middle east and africa pertussis vaccine market report 2017 across the world. Manufacturers have turned to technological innovations and data-driven customization to satisfy the augmenting consumer demand for efficiency and more accuracy in results, leading to an increased usage of technology in the Emea europe middle east and africa pertussis vaccine market report 2017 production processes, which is also reflecting positively on the growth of this market.

The research report on the Emea europe middle east and africa pertussis vaccine market report 2017 is an analytical study which comprehensively analyzes the competitive framework of this market. Using a number of effective assessment tools, such as porter’s five forces and value chain analysis, it performs in-depth analyses of the production and supply as well as the demand and sales of Emea europe middle east and africa pertussis vaccine market report 2017 and provides deep insights into the future prospects of this market.

The study begins with a detailed overview of the market for Emea europe middle east and africa pertussis vaccine market report 2017, including the definition, classification, and industry chain structure of Emea europe middle east and africa pertussis vaccine market report 2017, and move forward to cover every aspect of this market, counting several criteria based on which the market is classified. Focusing specifically on the key trends, it further evaluates the overall performance of this market during the assessment period. With chemical industry undergoing a phase of technological disruption, innovations in products are likely to shape the future of the Emea europe middle east and africa pertussis vaccine market report 2017.

In this research report, apart from the trends, the driving forces, restraints, and opportunities have also been taken into consideration to determine the market’s future. Further, it offers an estimation of the market size in terms of value (US$) and in volume (kilo tons) and talks about the key segments and the geographical subdivisions of the market for Emea europe middle east and africa pertussis vaccine market report 2017 in details. It provides in-depth information on the development trends and the policies and regulations, concerning Emea europe middle east and africa pertussis vaccine market report 2017, implemented in each of the geographical segments. The predominant applications of the Emea europe middle east and africa pertussis vaccine market report 2017 have also been discussed at length in this research study.

With all these analyses and information, this report can act as a valuable guide to readers looking to gain a clear understanding of all the factors that are influencing the market for Emea europe middle east and africa pertussis vaccine market report 2017 at present and are projected to remain doing so over the forecast period. Readers will also benefit significantly from the important information regarding this market, provided in the forms of figures and tables in the research report.

Additionally, the information on the latest developments in this market, both, at the global as well as regional level, is expected to enhance the decision-making capability of the reader. Up-to-date information on various specifications, buyer analysis, their purchasing volume, prices, and price analysis, and deep insights on the leading suppliers have also been provided in this study for the readers.

At last, the report offers key industry recommendations to companies looking to venture into the Emea europe middle east and africa pertussis vaccine market report 2017 from both the perspectives, i.e. demand and supply. The main objective of this research study is to assist stakeholders operating in this market in creating efficient counter strategies to gain an edge over their competitors.

List of Tables and Figures

Figure Product Picture of Pertussis Vaccine
Figure EMEA Pertussis Vaccine Sales Volume (K Units) by Type (2012-2022)
Figure EMEA Pertussis Vaccine Sales Volume Market Share by Type (Product Category) in 2016
Figure Whole-cell Vaccines Product Picture
Figure Acellular Vaccines Product Picture
Figure EMEA Pertussis Vaccine Sales Volume (K Units) by Application (2012-2022)
Figure EMEA Sales Market Share of Pertussis Vaccine by Application in 2016
Figure Children Application Examples
Figure Adults Application Examples
Figure EMEA Pertussis Vaccine Market Size (Million USD) by Region (2012-2022)
Figure Europe Pertussis Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Pertussis Vaccine Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Pertussis Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Pertussis Vaccine Revenue (Million USD) Status and Forecast by Countries
Figure Africa Pertussis Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Pertussis Vaccine Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Pertussis Vaccine Sales Volume and Growth Rate (2012-2022)
Figure EMEA Pertussis Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA Pertussis Vaccine Market Major Players Product Sales Volume (K Units) (2012-2017)
Table EMEA Pertussis Vaccine Sales Volume (K Units) of Major Players (2012-2017)
Table EMEA Pertussis Vaccine Sales Share by Players (2012-2017)
Figure 2016 Pertussis Vaccine Sales Share by Players
Figure 2017 Pertussis Vaccine Sales Share by Players
Figure EMEA Pertussis Vaccine Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA Pertussis Vaccine Revenue (Million USD) by Players (2012-2017)
Table EMEA Pertussis Vaccine Revenue Share by Players (2012-2017)
Table 2016 EMEA Pertussis Vaccine Revenue Share by Players
Table 2017 EMEA Pertussis Vaccine Revenue Share by Players
Table EMEA Pertussis Vaccine Sale Price (USD/Unit) by Players (2012-2017)
Table EMEA Pertussis Vaccine Sales (K Units) and Market Share by Type (2012-2017)
Table EMEA Pertussis Vaccine Sales Share by Type (2012-2017)
Figure Sales Market Share of Pertussis Vaccine by Type (2012-2017)
Figure EMEA Pertussis Vaccine Sales Market Share by Type (2012-2017)
Table EMEA Pertussis Vaccine Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA Pertussis Vaccine Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Pertussis Vaccine by Type in 2016
Table EMEA Pertussis Vaccine Sale Price (USD/Unit) by Type (2012-2017)
Table EMEA Pertussis Vaccine Sales (K Units) and Market Share by Application (2012-2017)
Table EMEA Pertussis Vaccine Sales Share by Application (2012-2017)
Figure Sales Market Share of Pertussis Vaccine by Application (2012-2017)
Figure EMEA Pertussis Vaccine Sales Market Share by Application in 2016
Table EMEA Pertussis Vaccine Sales (K Units) and Market Share by Region (2012-2017)
Table EMEA Pertussis Vaccine Sales Share by Region (2012-2017)
Figure Sales Market Share of Pertussis Vaccine by Region (2012-2017)
Figure EMEA Pertussis Vaccine Sales Market Share in 2016
Table EMEA Pertussis Vaccine Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA Pertussis Vaccine Revenue Share by Region (2012-2017)
Figure Revenue Market Share of Pertussis Vaccine by Region (2012-2017)
Figure EMEA Pertussis Vaccine Revenue Market Share Regions in 2016
Table EMEA Pertussis Vaccine Sales Price (USD/Unit) by Region (2012-2017)
Figure Europe Pertussis Vaccine Sales (K Units) and Growth Rate (2012-2017)
Figure Europe Pertussis Vaccine Revenue and Growth Rate (2012-2017)
Table Europe Pertussis Vaccine Sales (K Units) by Type (2012-2017)
Table Europe Pertussis Vaccine Market Share by Type (2012-2017)
Figure Europe Pertussis Vaccine Market Share by Type in 2016
Table Europe Pertussis Vaccine Sales (K Units) by Application (2012-2017)
Table Europe Pertussis Vaccine Market Share by Application (2012-2017)
Figure Europe Pertussis Vaccine Market Share by Application in 2016
Table Europe Pertussis Vaccine Sales (K Units) by Countries (2012-2017)
Table Europe Pertussis Vaccine Sales Market Share by Countries (2012-2017)
Figure Europe Pertussis Vaccine Sales Market Share by Countries (2012-2017)
Figure Europe Pertussis Vaccine Sales Market Share by Countries in 2016
Table Europe Pertussis Vaccine Revenue (Million USD) by Countries (2012-2017)
Table Europe Pertussis Vaccine Revenue Market Share by Countries (2012-2017)
Figure Europe Pertussis Vaccine Revenue Market Share by Countries (2012-2017)
Figure Europe Pertussis Vaccine Revenue Market Share by Countries in 2016
Figure Germany Pertussis Vaccine Sales (K Units) and Growth Rate (2012-2017)
Figure France Pertussis Vaccine Sales (K Units) and Growth Rate (2012-2017)
Figure UK Pertussis Vaccine Sales (K Units) and Growth Rate (2012-2017)
Figure Russia Pertussis Vaccine Sales (K Units) and Growth Rate (2012-2017)
Figure Italy Pertussis Vaccine Sales (K Units) and Growth Rate (2012-2017)
Figure Benelux Pertussis Vaccine Sales (K Units) and Growth Rate (2012-2017)
Figure Middle East Pertussis Vaccine Sales (K Units) and Growth Rate (2012-2017)
Figure Middle East Pertussis Vaccine Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East Pertussis Vaccine Sales (K Units) by Type (2012-2017)
Table Middle East Pertussis Vaccine Market Share by Type (2012-2017)
Figure Middle East Pertussis Vaccine Market Share by Type (2012-2017)
Table Middle East Pertussis Vaccine Sales (K Units) by Applications (2012-2017)
Table Middle East Pertussis Vaccine Market Share by Applications (2012-2017)
Figure Middle East Pertussis Vaccine Sales Market Share by Application in 2016
Table Middle East Pertussis Vaccine Sales Volume (K Units) by Countries (2012-2017)
Table Middle East Pertussis Vaccine Sales Volume Market Share by Countries (2012-2017)
Figure Middle East Pertussis Vaccine Sales Volume Market Share by Countries in 2016
Table Middle East Pertussis Vaccine Revenue (Million USD) by Countries (2012-2017)
Table Middle East Pertussis Vaccine Revenue Market Share by Countries (2012-2017)
Figure Middle East Pertussis Vaccine Revenue Market Share by Countries (2012-2017)
Figure Middle East Pertussis Vaccine Revenue Market Share by Countries in 2016
Figure Saudi Arabia Pertussis Vaccine Sales (K Units) and Growth Rate (2012-2017)
Figure Israel Pertussis Vaccine Sales (K Units) and Growth Rate (2012-2017)
Figure UAE Pertussis Vaccine Sales (K Units) and Growth Rate (2012-2017)
Figure Iran Pertussis Vaccine Sales (K Units) and Growth Rate (2012-2017)
Figure Africa Pertussis Vaccine Sales (K Units) and Growth Rate (2012-2017)
Figure Africa Pertussis Vaccine Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa Pertussis Vaccine Sales (K Units) by Type (2012-2017)
Table Africa Pertussis Vaccine Sales Market Share by Type (2012-2017)
Figure Africa Pertussis Vaccine Sales Market Share by Type (2012-2017)
Figure Africa Pertussis Vaccine Sales Market Share by Type in 2016
Table Africa Pertussis Vaccine Sales (K Units) by Application (2012-2017)
Table Africa Pertussis Vaccine Sales Market Share by Application (2012-2017)
Figure Africa Pertussis Vaccine Sales Market Share by Application (2012-2017)
Table Africa Pertussis Vaccine Sales Volume (K Units) by Countries (2012-2017)
Table Africa Pertussis Vaccine Sales Market Share by Countries (2012-2017)
Figure Africa Pertussis Vaccine Sales Market Share by Countries (2012-2017)
Figure Africa Pertussis Vaccine Sales Market Share by Countries in 2016
Table Africa Pertussis Vaccine Revenue (Million USD) by Countries (2012-2017)
Table Africa Pertussis Vaccine Revenue Market Share by Countries (2012-2017)
Figure Africa Pertussis Vaccine Revenue Market Share by Countries (2012-2017)
Figure Africa Pertussis Vaccine Revenue Market Share by Countries in 2016
Figure South Africa Pertussis Vaccine Sales (K Units) and Growth Rate (2012-2017)
Figure Nigeria Pertussis Vaccine Sales (K Units) and Growth Rate (2012-2017)
Figure Egypt Pertussis Vaccine Sales (K Units) and Growth Rate (2012-2017)
Figure Algeria Pertussis Vaccine Sales (K Units) and Growth Rate (2012-2017)
Table Sanofi Pasteur Pertussis Vaccine Basic Information List
Table Sanofi Pasteur Pertussis Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Sanofi Pasteur Pertussis Vaccine Sales (K Units) and Growth Rate (2012-2017)
Figure Sanofi Pasteur Pertussis Vaccine Sales Market Share in EMEA (2012-2017)
Figure Sanofi Pasteur Pertussis Vaccine Revenue Market Share in EMEA (2012-2017)
Table GSK Pertussis Vaccine Basic Information List
Table GSK Pertussis Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure GSK Pertussis Vaccine Sales (K Units) and Growth Rate (2012-2017)
Figure GSK Pertussis Vaccine Sales Market Share in EMEA (2012-2017)
Figure GSK Pertussis Vaccine Revenue Market Share in EMEA (2012-2017)
Table Mitsubishi Tanabe Pharma Corporation Pertussis Vaccine Basic Information List
Table Mitsubishi Tanabe Pharma Corporation Pertussis Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Mitsubishi Tanabe Pharma Corporation Pertussis Vaccine Sales (K Units) and Growth Rate (2012-2017)
Figure Mitsubishi Tanabe Pharma Corporation Pertussis Vaccine Sales Market Share in EMEA (2012-2017)
Figure Mitsubishi Tanabe Pharma Corporation Pertussis Vaccine Revenue Market Share in EMEA (2012-2017)
Table Astellas Pharma Pertussis Vaccine Basic Information List
Table Astellas Pharma Pertussis Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Astellas Pharma Pertussis Vaccine Sales (K Units) and Growth Rate (2012-2017)
Figure Astellas Pharma Pertussis Vaccine Sales Market Share in EMEA (2012-2017)
Figure Astellas Pharma Pertussis Vaccine Revenue Market Share in EMEA (2012-2017)
Table Minhai Biotechnology Pertussis Vaccine Basic Information List
Table Minhai Biotechnology Pertussis Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Minhai Biotechnology Pertussis Vaccine Sales (K Units) and Growth Rate (2012-2017)
Figure Minhai Biotechnology Pertussis Vaccine Sales Market Share in EMEA (2012-2017)
Figure Minhai Biotechnology Pertussis Vaccine Revenue Market Share in EMEA (2012-2017)
Table Wuhan Institute of Biological Products Pertussis Vaccine Basic Information List
Table Wuhan Institute of Biological Products Pertussis Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Wuhan Institute of Biological Products Pertussis Vaccine Sales (K Units) and Growth Rate (2012-2017)
Figure Wuhan Institute of Biological Products Pertussis Vaccine Sales Market Share in EMEA (2012-2017)
Figure Wuhan Institute of Biological Products Pertussis Vaccine Revenue Market Share in EMEA (2012-2017)
Table Changchun Changsheng Life Sciences Pertussis Vaccine Basic Information List
Table Changchun Changsheng Life Sciences Pertussis Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Changchun Changsheng Life Sciences Pertussis Vaccine Sales (K Units) and Growth Rate (2012-2017)
Figure Changchun Changsheng Life Sciences Pertussis Vaccine Sales Market Share in EMEA (2012-2017)
Figure Changchun Changsheng Life Sciences Pertussis Vaccine Revenue Market Share in EMEA (2012-2017)
Table Beijing Tiantan Biological Products Pertussis Vaccine Basic Information List
Table Beijing Tiantan Biological Products Pertussis Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Beijing Tiantan Biological Products Pertussis Vaccine Sales (K Units) and Growth Rate (2012-2017)
Figure Beijing Tiantan Biological Products Pertussis Vaccine Sales Market Share in EMEA (2012-2017)
Figure Beijing Tiantan Biological Products Pertussis Vaccine Revenue Market Share in EMEA (2012-2017)
Table Chengdu Institute of Biological Products Pertussis Vaccine Basic Information List
Table Chengdu Institute of Biological Products Pertussis Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Chengdu Institute of Biological Products Pertussis Vaccine Sales (K Units) and Growth Rate (2012-2017)
Figure Chengdu Institute of Biological Products Pertussis Vaccine Sales Market Share in EMEA (2012-2017)
Figure Chengdu Institute of Biological Products Pertussis Vaccine Revenue Market Share in EMEA (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Pertussis Vaccine
Figure Manufacturing Process Analysis of Pertussis Vaccine
Figure Pertussis Vaccine Industrial Chain Analysis
Table Raw Materials Sources of Pertussis Vaccine Major Manufacturers in 2016
Table Major Buyers of Pertussis Vaccine
Table Distributors/Traders List
Figure EMEA Pertussis Vaccine Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure EMEA Pertussis Vaccine Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA Pertussis Vaccine Price (USD/Unit) and Trend Forecast (2017-2022)
Table EMEA Pertussis Vaccine Sales (K Units) Forecast by Region (2017-2022)
Figure EMEA Pertussis Vaccine Sales Market Share Forecast by Region (2017-2022)
Table EMEA Pertussis Vaccine Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA Pertussis Vaccine Revenue Market Share Forecast by Region (2017-2022)
Table Europe Pertussis Vaccine Sales (K Units) Forecast by Countries (2017-2022)
Figure Europe Pertussis Vaccine Sales Market Share Forecast by Countries (2017-2022)
Table Europe Pertussis Vaccine Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe Pertussis Vaccine Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Pertussis Vaccine Sales (K Units) Forecast by Countries (2017-2022)
Figure Middle East Pertussis Vaccine Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Pertussis Vaccine Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East Pertussis Vaccine Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Pertussis Vaccine Sales (K Units) Forecast by Countries (2017-2022)
Figure Africa Pertussis Vaccine Sales Market Share Forecast by Countries (2017-2022)
Table Africa Pertussis Vaccine Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa Pertussis Vaccine Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Pertussis Vaccine Sales (K Units) Forecast by Type (2017-2022)
Figure EMEA Pertussis Vaccine Sales Market Share Forecast by Type (2017-2022)
Table EMEA Pertussis Vaccine Sales (K Units) Forecast by Application (2017-2022)
Figure EMEA Pertussis Vaccine Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Send an Enquiry

  • * :
  • * :
  • * :
  • * :
  • * :
  • :
  • * :
  • * indicates required field.

LATEST NEWS


Back To Top